The researchers built a tiny device with a spring that ejects a tiny dart of solid insulin into the wall of the stomach, said researcher Carlo Giovanni Traverso, PhD.
“We chose the stomach as the site of delivery because we recognized that the stomach is a thick and robust part of the GI tract,” Dr. Traverso said.
When the device gets into the stomach, the humidity there lets the spring launch the insulin dart.
The researchers have tested the device on pigs and found it can deliver a therapeutic dose of insulin if the pig has an empty stomach. They published their findings in Science.
They are now working with the global healthcare company Novo Nordisk to prepare the device for human testing.
More articles on clinical leadership & infection control:
13 patients harmed by care at Johns Hopkins All Children’s, system says
VA hospitals report lower death rates than non-VA facilities, USA Today finds
10 growth opportunities for precision imaging, as outlined by Frost & Sullivan
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.